These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 4937989)

  • 1. Controlled, double-blind trial of antiplatelet aggregating agents in vascular renal allograft rejection.
    Mathew TH; Hogan GP; Lewers DT; Bauer H; Maher JF; Schreiner GE
    Transplant Proc; 1971 Mar; 3(1):901-4. PubMed ID: 4937989
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical experience with antilymphocyte globulin (ALG) in renal transplantation.
    Deodhar SD; Konomi K; Nakamoto S; Kuruvila KC
    Transplant Proc; 1971 Mar; 3(1):758-61. PubMed ID: 4937968
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of immunosuppressive agents and matching on pulmonary allografts.
    Motlagh FA; Dutta SK; Paley N; Karlson KE; Garzon AA
    Surg Forum; 1970; 21():196-8. PubMed ID: 4936968
    [No Abstract]   [Full Text] [Related]  

  • 4. Controlled clinical trial of antilymphocyte globulin in human renal allografts.
    Birtch AG; Carpenter CB; Tilney NL; Hampers CL; Hager FB; Levine L; Wilson RE; Murray JE
    Transplant Proc; 1971 Mar; 3(1):762-5. PubMed ID: 4937969
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of 2'-(3-dimethylaminopropylthio) cinnamanilide on dog renal allograft survival.
    Amundsen B; Lakey WH
    Surg Forum; 1970; 21():254-6. PubMed ID: 4936978
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelets in early hyperacute allograft rejection in kidneys and their modification by sulfinpyrazone (Anturan) therapy. An experimental study.
    Sharma HM; Moore S; Merrick HW; Smith MR
    Am J Pathol; 1972 Mar; 66(3):445-60. PubMed ID: 4551295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allograft prolongation with synthetic progestins.
    Turcotte JG; Niederhuber JE; Haines RF; Gikas PW
    Transplant Proc; 1971 Mar; 3(1):814-8. PubMed ID: 4937974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of blood transfusions on antibody formation and canine renal allograft survival.
    Currier CB; Pierce JC
    Surg Gynecol Obstet; 1974 Aug; 139(2):241-4. PubMed ID: 4601702
    [No Abstract]   [Full Text] [Related]  

  • 9. A histological technique for assaying the efficacy of methods designed to reduce allograft rejection.
    Stewart PA; Swinney J
    Br J Surg; 1972 Apr; 59(4):312. PubMed ID: 4553602
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal allograft survival in bone marrow chimeras.
    Hussey JL; Daouk A; Elhabashi S; Kisken WA
    Surg Forum; 1971; 22():233-5. PubMed ID: 4399270
    [No Abstract]   [Full Text] [Related]  

  • 11. A controlled trial of dipyridamole in human renal transplantation and an assessment of platelet function studies in rejection.
    Anderson M; Dewar P; Fleming LB; Hacking PM; Morley AR; Murray S; Swinney J; Taylor RM; Uldall PR; Wardle EN
    Clin Nephrol; 1974; 2(3):93-9. PubMed ID: 4603996
    [No Abstract]   [Full Text] [Related]  

  • 12. Humoral antibody in canine cardiac allograft rejection.
    Goldman BS; Shumak KH; Cartier J; Silver MD; Bigelow WG; Crookston JH
    Circulation; 1971 May; 43(5 Suppl):I115-9. PubMed ID: 4931285
    [No Abstract]   [Full Text] [Related]  

  • 13. The platelet in the obliterate vascular rejection phenomenon.
    Burrows L; Haimov M; Aledort L; Leiter E; Nirmul G; Shanzer H; Taub R; Glabman S
    Transplant Proc; 1973 Mar; 5(1):157-60. PubMed ID: 4572094
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunological enhancement: strategy for clinical renal transplantation.
    Batchelor JR
    Proc Eur Dial Transplant Assoc; 1977; 14():251-8. PubMed ID: 341125
    [No Abstract]   [Full Text] [Related]  

  • 15. Specific suppression of renal allograft rejection by treatment with antigen and antibody.
    Stuart FP; Fitch FW; Rowley DA
    Transplant Proc; 1970 Dec; 2(4):483-8. PubMed ID: 4939695
    [No Abstract]   [Full Text] [Related]  

  • 16. Transplantation of the intestine and pancreas.
    Lillehei RC; Idezuki Y; Kelly WD; Najarian JS; Merkel FK; Goetz FC
    Transplant Proc; 1969 Mar; 1(1):230-8. PubMed ID: 4944222
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlation of platelet aggregation in canine renal allotransplants with serum cytotoxic antibody following treatment with azathioprine.
    Lowenhaupt RW; Nathan P; Menefee MG
    Transplant Proc; 1971 Mar; 3(1):453-6. PubMed ID: 4937917
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of heparin and dipyridamole on chronic vascular lesions in monkey cardiac allografts.
    Kahn DR; Dufek JH; Oberman HA; Beck ML; Bree M; Kirsh MM; Moores WY; Prior M
    J Thorac Cardiovasc Surg; 1972 May; 63(5):720-2. PubMed ID: 4623898
    [No Abstract]   [Full Text] [Related]  

  • 19. Relevance of mixed lymphocyte reactions to renal allograft rejection mechanisms.
    Lindquist RR; Guttmann RD
    Transplant Proc; 1971 Mar; 3(1):879-82. PubMed ID: 4937985
    [No Abstract]   [Full Text] [Related]  

  • 20. Humoral factors in experimental renal allograft and xenograft rejection.
    Chavez-Peon F; Monchik G; Winn HJ; Russell PS
    Transplant Proc; 1971 Mar; 3(1):573-6. PubMed ID: 4937941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.